SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005286-24-000145
Filing Date
2024-10-04
Accepted
2024-10-04 07:41:36
Documents
90
Period of Report
2024-08-25

Document Format Files

Seq Description Document Type Size
1 10-Q lfcr-20240825.htm   iXBRL 10-Q 973683
2 EX-31.1 lfcr-20240825xexx311.htm EX-31.1 11745
3 EX-31.2 lfcr-20240825xexx312.htm EX-31.2 12170
4 EX-32.1 lfcr-20240825xexx321.htm EX-32.1 5716
5 EX-32.2 lfcr-20240825xexx322.htm EX-32.2 5817
  Complete submission text file 0001005286-24-000145.txt   6964546

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfcr-20240825.xsd EX-101.SCH 42511
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfcr-20240825_cal.xml EX-101.CAL 71046
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfcr-20240825_def.xml EX-101.DEF 310837
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfcr-20240825_lab.xml EX-101.LAB 673169
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfcr-20240825_pre.xml EX-101.PRE 505658
93 EXTRACTED XBRL INSTANCE DOCUMENT lfcr-20240825_htm.xml XML 853335
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: 10-Q | Act: 34 | File No.: 000-27446 | Film No.: 241353506
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)